LIR-1 EDUCATES EXPANDED HUMAN NK CELLS AND DEFINES A UNIQUE NK CELL SUBSET WITH POTENT ADCC CAPACITY ATTRACTIVE FOR CANCER IMMUNOTHERAPY ACROSS HLA BARRIERS

EHA Library, Caroline Leijonhufvud, 324220

A PAN-CANCER ANALYSIS OF THE SUPPRESSOR ROLE OF ACETYL-COA ACETYLTRANSFERASE 1 IN TUMORS

EHA Library, Xinting Hu, 324221

THE IMPLEMENTATION OF BLOOD CANCER BIOBANKING IN GALWAY UNIVERSITY HOSPITAL

EHA Library, Annmarie Wrafter, 324222

SECONDARY HYPERPARATHYROIDISM AND ERYTHROPOETIN-STIMULATING-AGENT REFRACTORY ANEMIA: A CASE OF REVERSIBLE TRANSFUSION DEPENDENCE

EHA Library, Bilal Ashraf, 324224

A POSSIBLE NEW MUTATION IN DNMT3A AS A MARKER OF CLONAL HEMATOPOIESIS

EHA Library, Pavel Lipilkin, 324225

RISK FACTORS FOR THE OCCURRENCE OF BLEOMYCIN-INDUCED LUNG TOXICITY IN THE ERA OF POSITRON EMISSION TOMOGRAPHY.

EHA Library, Selim Jennane, 324228

PROGNOSTIC FACTORS OF WORSE SURVIVAL IN NEWLY DIAGNOSED ADVANCED-STAGE HODGKIN LYMPHOMA IN TAIWAN: A NATIONWIDE RETROSPECTIVE STUDY

EHA Library, Tran-Der Tan, 324229

BRENTUXIMAB VEDOTIN IN COMBINATION WITH NIVOLUMAB, DOXORUBICIN, AND DACARBAZINE IN NEWLY DIAGNOSED PATIENTS WITH ADVANCED HODGKIN LYMPHOMA (SGN35-027, TRIAL IN PROGRESS)

EHA Library, Ian W. Flinn, 324230

RETROSPECTIVE STUDY TO DESCRIBE TREATMENT PATHWAYS, OUTCOMES, AND RESOURCE USE IN PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA (B-HOLISTIC): RESULTS FROM THE SUBGROUP ANALYSIS OF PATIENTS FROM CHINA

EHA Library, Yuqin Song, 324232

LONG-TERM OUTCOME OF HODGKIN’S LYMPHOMA CASES IN A POPULATION-BASED CANCER CENTER

EHA Library, Salem Alshemmari, 324234

HODGKIN'S LYMPHOMA IN ADOLESCENTS TREATED WITH ABVD

EHA Library, S.M.Amine BENLAZAR, 324235

EARLY DISEASE PROGRESSION PREDICTS SHORTER SURVIVAL IN PATIENTS TREATED FOR HODGKIN LYMPHOMA.

EHA Library, S.M.Amine BENLAZAR, 324236

INTERIM PET BASED OMISSION OF RADIOTHERAPY OR INTENSIFICATION OF CHEMOTHERAPY IN YOUNGER PATIENTS WITH LOCALIZED STAGE CLASSICAL HODGKIN LYMPHOMA: PRELIMINARY EXPERIENCE FROM A SINGLE REFERRAL CENTER

EHA Library, Marina Belia, 324237

ACUTE NEUROLOGIC DETERIORATION FOLLOWING THREE DOSES OF BRENTUXIMAB-VEDOTIN IN A PATIENT WITH CHARCOT-MARIE-TOOTH DISEASE

EHA Library, HARIDIAN DE LA NUEZ MELIAN, 324238

IS THERE ANY CORRELATION BETWEEN THE HISTORY OF FAMILIAL NEOPLASIA AND THE DESCRIPTIVE AND PROGRESSIVE PROFILE OF HODGKIN LYMPHOMAS? 4-YEAR COHORT STUDY

EHA Library, Talbi Faiza, 324240

THERAPEUTIC RESULTS OF A TUNISIAN PROSPECTIVE NON-RANDOMIZED ADULT HODGKIN LYMPHOMA STUDY: SINGLE-INSTITUTION EXPERIENCE ABOUT 73 ADULT PATIENTS

EHA Library, Faten kallel, 324241

A PHASE III TRIAL (GO42909) EVALUATING MOSUNETUZUMAB IN COMBINATION WITH LENALIDOMIDE (M-LEN) VERSUS RITUXIMAB-LENALIDOMIDE (R-LEN) IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)

EHA Library, Christian W. Scholz, 324242

THE PROGNOSTIC NUTRITIONAL INDEX (PNI) IS AN INDEPENDENT PREDICTOR OF OVERALL SURVIVAL IN OLDER PATIENTS WITH FOLLICULAR LYMPHOMA

EHA Library, Pablo Mozas, 324244

PROGNOSTIC PERFORMANCE OF CLINICAL RISK SCORES IN FOLLICULAR LYMPHOMA: EVALUATION IN A SINGLE-CENTER SERIES

EHA Library, Pablo Mozas, 324245

COASTAL: A PHASE 3 STUDY OF THE PI3KΔ INHIBITOR ZANDELISIB WITH RITUXIMAB (R) VERSUS IMMUNOCHEMOTHERAPY IN PATIENTS WITH RELAPSED INDOLENT NON-HODGKIN’S LYMPHOMA (INHL)

EHA Library, Wojciech Jurczak, 324246

A PHASE 2 RANDOMIZED STUDY OF LONCASTUXIMAB TESIRINE VERSUS IDELALISIB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (LOTIS-6)

EHA Library, Carmelo Carlo-Stella, 324247

OUTCOMES OF BENDAMUSTINE + RITUXIMAB FIRST-LINE THERAPY IN PATIENTS WITH INDOLENT NON-HODGKIN’S LYMPHOMA OR MANTLE CELL LYMPHOMA: REAL WORLD EXPERIENCE

EHA Library, Rouslan Kotchetkov, 324250

ASSOCIATION OF DISEASE HISTORY DURATION AND SURVIVAL RATES IN FOLLICULAR LYMPHOMA PATIENTS AS A NEW FACTOR OF UNFAVORABLE PROGNOSIS.

EHA Library, Sergey Kravchenko, 324251

TOWARDS PERSONALIZED MEDICINE FOR RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA PATIENTS: THE CANTERA LUPIAE REGISTRY

EHA Library, Sanne Tonino, 324252

CONVENTIONAL INTERVENTIONS FAILED TO PROVIDE SURVIVAL BENEFIT FOR EARLY-STAGE MAJOR SALIVARY GLAND MARGINAL ZONE LYMPHOMA

EHA Library, Lei Fan, 324253

HAIRY CELL LEUKEMIA: SINGLE CENTER EXPERIENCE

EHA Library, Ziad Emarah, 324255

MYD88 MUTATION IN WALDENSTROMSÖM MACROGLOBULINEMIA AND TREATMENT OUTCOME. A SINGLE CENTRE EXPERIENCE

EHA Library, Aiste Konenko, 324256

RETROSPECTIVE STUDY ON MANTLE CELL LYMPHOMA (MCL) AND TREATMENT OUT-COME- A SINGLE CENTER EXPERIENCE.

EHA Library, Ezzat Elhassadi, 324257

PROGNOSTIC SIGNIFICANCE OF NEUTROPHIL-TO-LYMPHOCYTE RATIO IN THE DETERMINATION OF SEVERE PROGNOSIS OF HEMATOLOGICAL PATIENTS WITH COVID-19 INFECTION. DATA OF MOLDOVAN HEMATOLOGICAL CENTER.

EHA Library, Victor Tomacinschii, 324259

SARS-COV-2 INFECTION IN HAEMATOLOGICAL PATIENTS: DESCRIPTIVE COHORT STUDY OF HOSPITALIZED PATIENTS IN A TERTIARY CARE CENTER

EHA Library, Ana Maria Hoyos Brea, 324261

BACTEREMIA IN PEDIATRIC PATIENTS WITH HEMATOLOGIC MALIGNANCIES

EHA Library, BECHIR ACHOUR, 324263

HEPATITIS B AND C IN ACUTE LYMPHOBLASTIC LEUKEMIAA 2-YEAR STUDY 2015-2016 AT CHILDREN WELFARE TEACHING HOSPITAL

EHA Library, Hasanein Ghali, 324266

ETIOLOGICAL CHARACTERISTICS OF BLOODSTREAM INFECTION PATOGENS IN PATIENT WITH ACUTE MYELOID LEUKEMIA

EHA Library, Maryna Tsiarentsyeva, 324267

GEOTRICHUM CAPITATUM SEPTICEMIA IN NEUTOPENIC PATIENTS WITH ACUTE LEUKEMIA

EHA Library, Imen Ben Amor, 324269

A NOVEL PREDICTIVE SCORING MODEL FOR PREDICTING INFECTION

EHA Library, Mei Hong, 324270

REVIEW OF ANTIFUNGAL PROPHYLAXIS PRACTICES AND INCIDENCE OF BREATHROUGH FUNGAL INFECTIONS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES

EHA Library, Jessica Muscat, 324272

HEMATOLOGIC PARAMETERS IN ASYMPTOMATIC PATIENTS WITH ACTIVE COVID-19 INFECTION.

EHA Library, Mounir Ababou, 324275

INFECTION PROFILE AND OUTCOMES OF ADULT ACUTE LEUKEMIA PATIENTS DEVELOPING CHEMOTHERAPY-ASSOCIATED FEBRILE NEUTROPENIA AT THE PHILIPPINE GENERAL HOSPITAL

EHA Library, Camille Ariadne Tanchanco, 324277

SET UP OF A GENE PANEL FOR NEXT GENERATION SEQUENCING IN THE CAUSES OF ERYTHROCYTOSIS

EHA Library, Andrea Benetti, 324278

EXTRAVASATION OF INTRAVENOUS IRON INFUSION։ A CASE REPORT

EHA Library, Evaggelia Vetsiou, 324285

THIAMINE REVERSAL OF LACTIC ACIDOSIS IN HIGH BURDEN HEMATOLOGICAL MALIGNANCY: CASE SERIES

EHA Library, Kamal Alzahrani, 324286

CLONALITY ANALYSIS IN FOLLOW-UP OF PATIENTS WITH NON-HODGKIN LYMPHOMA

EHA Library, Ira Koković, 324287

TUMOR-NONSPECIFIC METHYLATION OF THE MIR-145 GENE IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Elena Voropaeva, 324288

COMBINING FLOW CYTOMETRY AND MOLECULAR GENETICS FOR PROGNOSIS IN MYELODYSPLASTIC SYNDROME

EHA Library, Nikolai Tcvetkov, 324289

SUPPRESSION OF AKR1B1 REDUCES CELL PROLIFERATION AND ENHANCES SENSITIVITY TO HYPOMETHYLATING AGENTS BY INHIBITING MTORC1 SIGNALING PATHWAY IN HIGH-RISK MYELODYSPLASTIC SYNDROME

EHA Library, Hongyan Tong, 324290

AKT KINASE REGULATES TIM-3 EXPRESSION IN MYELOID NEOPLASMS

EHA Library, Anna Parfenenkova, 324294

POLYMORPHISM OF GSTM1, GSTT1 AND CYTOKINE GENES IN PATIENTS WITH MYELODYSPLASTIC SYNDROME

EHA Library, Zhanna Sidorova, 324295

MUTATIONAL ANALYSIS IN LOW RISK MYELODYSPLASTIC SYNDROMES: A SINGLE CENTER REPORT

EHA Library, Giulio Cassanello, 324298

MAGROLIMAB + AZACITIDINE VERSUS AZACITIDINE + PLACEBO IN UNTREATED, HIGHER-RISK (HR) MYELODYSPLASTIC SYNDROME: THE PHASE 3, RANDOMIZED, ENHANCE STUDY

EHA Library, Guillermo Garcia-Manero, 324299

TREATMENTS AND OUTCOMES FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS) BY REVISED INTERNATIONAL PROGNOSTIC SCORING SYSTEM (IPSS-R) SCORES AT THE HUNTSMAN CANCER INSTITUTE

EHA Library, Connor Willis, 324300

A PHASE 1/2, OPEN-LABEL, MULTICENTER STUDY OF INCB000928 MONOTHERAPY IN PATIENTS WITH ANEMIA DUE TO MYELODYSPLASTIC SYNDROMES OR MULTIPLE MYELOMA

EHA Library, Jean-Marie Michot, 324301

ALLOGENEIC STEM CELL TRANSPLANTATION IN 34 PATIENTS WITH MYELODYSPLASTIC SYNDROME

EHA Library, Malek Benakli, 324304

ROLE OF PROTEIN KINASE CK1 ALPHA AND LENALIDOMIDE IN THE INTERACTIONS BETWEEN MULTIPLE MYELOMA PLASMA CELLS AND BONE MARROW STROMAL CELLS: THERAPEUTIC IMPLICATIONS

EHA Library, Anna Fregnani, 324307

THE FIRST MYELOMA PATIENT DERIVED XENOGRAFT FROM TREATMENT REFRACTORY HUMAN MYELOMA CELLS IN SWEDEN AND THE EFFECT OF BROMODOMAIN-INHIBITORS ON MYELOMA CELLS IN VIVO

EHA Library, David Jansson, 324308

GLOBAL DNA METHYLATION AND PROMOTER GENE METHYLATION IN MGUS AND DIFFERENT STAGES OF MULTIPLE MYELOMA

EHA Library, Pavla Flodrova, 324311

PROGNOSTIC ROLE OF MONOMERIC C-REACTIVE PROTEIN IN NEWLY DIAGNOSED MULTIPLE MYELOMA AS A MARKER OF THE BONE LOSS DEGREE

EHA Library, Sergey Semochkin, 324312

VALIDATION OF ALGORITHMS TO IDENTIFY FIRST-LINE THERAPY (INDUCTION AND MAINTENANCE) FOR MULTIPLE MYELOMA FOR USE IN ELECTRONIC HEALTHCARE DATABASES

EHA Library, Ariel Berger, 324313

FIRST CASE OF SYSTEMIC LIGHT CHAIN (AL) AMYLOIDOSIS TREATED WITH ANTI-B CELL MATURATION ANTIGEN -CAR T CELLS

EHA Library, Aina Oliver Caldés, 324316

THE NATURAL HISTORY OF SYSTEMIC AL AMYLOIDOSIS FOLLOWING UPFRONT TREATMENT WITH BORTEZOMIB: AN ANALYSIS OF REAL-WORLD LONGITUDINAL DATA

EHA Library, Sriram Ravichandran, 324318

A CLINICAL-DECISION TOOL TO IMPROVE THE STRATEGY OF MULTIPLE MYELOMA TREATMENT

EHA Library, Alexander Luchinin, 324319

REAL-WORLD DRUG USE AND COMPLEMENTARY AND ALTERNATIVE MEDICINES PRACTICE IN LYMPHOMA PATIENTS TREATED WITH CAR T CELLS IN A FRENCH UNIVERSITY HOSPITAL

EHA Library, Catherine Rioufol, 324223

SPONTANEOUS APOPTOSIS IN THE CULTURE OF BONE MARROW`S MESENCHYMAL STROMAL CELLS

EHA Library, Maria Butolina, 324226

LATE TOXICITIES IN CLASSICAL HODGKIN LYMPHOMA AND DIFFUSE LARGE B-CELL LYMPHOMA SURVIVORS AND LONG-TERM MONITORING: A SERIES OF SYSTEMATIC REVIEWS OF THE FONDAZIONE ITALIANA LINFOMI

EHA Library, Carla Minoia, 324227

OUTCOMES AFTER INITIAL REFUSAL OF CURATIVE TREATMENT IN PATIENTS WITH HODGKIN LYMPHOMA IN BRITISH COLUMBIA

EHA Library, Manik Chahal, 324231

THE PARTICULARITY OF MANAGEMENT OF PEDIATRIC HODGKIN LYMPHOMA IN TUNISIA: MONOCENTRIC STUDY

EHA Library, Raoudha Mansouri, 324233

BULKY MEDIASTINAL DISEASE IN HODGKIN LYMPHOMA: THERAPEUTIC OUTCOMES OF ABVD VERSUS BEACOPP ESCALATED REGIMEN IN A SINGLE TUNISIAN CENTER

EHA Library, Faten kallel, 324239

TRIAL IN PROGRESS: A PHASE 2, SINGLE-ARM, OPEN-LABEL, MULTICENTER STUDY OF TAZEMETOSTAT IN COMBINATION WITH RITUXIMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA

EHA Library, Krish Patel, 324243

CLINICAL OUTCOMES IN PATIENTS RELAPSED/REFRACTORY AFTER ≥ 2 PRIOR LINES OF THERAPY FOR FOLLICULAR LYMPHOMA: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS

EHA Library, Steve Kanters, 324248

PHASE 3 STUDY OF TAFASITAMAB + LENALIDOMIDE AND RITUXIMAB VS PLACEBO + LENALIDOMIDE AND RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) OR MARGINAL ZONE LYMPHOMA (MZL): INMIND

EHA Library, Christian W. Scholz, 324249

EARLY STAGE FOLLICULAR LYMPHOMA: A CURABLE DISEASE? LONG-TERM FOLLOW-UP FROM A SINGLE UNIT.

EHA Library, Stavrianna Diavati, 324254

PEGFILGRASTIM IN THE SUPPORTIVE CARE OF HEAVILY PRETREATED MULTIPLE MYELOMA IN POMALIDOMIDE-BASED TREATMENT

EHA Library, Claudio Cerchione, 324258

COVID-19 OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A SINGLE CENTER EXPERIENCE

EHA Library, Nikolaos Spyridis, 324260

CLINICAL CHARCTERISTICS AND RISK FACTORS OF SEVERITY OF COVID19 INFECTION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

EHA Library, Rym El Fatmi, 324262

INCIDENCE OF CELL-MEDIATED IMMUNODEFICIENCY-RELATED INFECTIOUS DISEASES IN THE HEMATOLOGIC DEPARTMENT OF A COMMUNITY HOSPITAL: A SINGLE INSTITUTION RETROSPECTIVE ANALYSIS

EHA Library, Naoto Imoto, 324264

REAL-WORLD GLUCARPIDASE UTILIZATION IN MALIGNANT HEMATOLOGY PATIENTS RECEIVING HIGH-DOSE METHOTREXATE: A SINGLE INSTITUTION EXPERIENCE

EHA Library, Julio Chavez, 324265

A SCORING SYSTEM FOR PREDICTING THE PROGNOSIS OF LATE-ONSET SEVERE PNEUMONIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Le-Qing Cao, 324268

NEXT-GENERATION SEQUENCING RAPIDLY IDENTIFY PATHOGENIC MICROBE IN BRONCHOALVEOLAR LAVAGE LIQUID OBTAINED FROM PATIENTS FAILED MULTIPLE LINES OF EMPIRICAL ANTI-MICROBIAL TREATMENT

EHA Library, xm fei, 324271

THROMBOELASTOMETRY AND CONVENTIONAL COAGULATION TESTS AS PREDICTORS OF PROGRESSION TO CRITICAL PHASE IN PATIENTS IN THE FEBRILE PHASE OF DENGUE FEVER: A PRELIMINARY PROSPECTIVE CASE CONTROL STUDY

EHA Library, Ahalyaa Sivashangar, 324273

COVID-19 AND MALIGNANT HEMOPATHIES: EXPERIENCE OF THE CLINICAL HEMATOLOGY SERVICE OF THE UNIVERSITY HOSPITAL CENTER IBN SINA IN RABAT

EHA Library, hajar khibri, 324274

BENEFIT OF TREATMENT WITH TOCILIZUMAB IN HEMOPHAGOCYTIC LYMPHYSTIOCYTOSIS SECONDARY TO VISCERAL LEISHMANIASIS INFECTION.

EHA Library, Maria Elena Cornejo Calvo, 324276

IMPACT OF THE COVID-19 PANDEMIC IN THE MR AVAILABILITY FOR IRON OVERLOADED PATIENTS

EHA Library, Antonella Meloni, 324279

PROSPECTIVE ANALYSIS OF DIFFERENT ORAL IRON POSOLOGY ON CLINICAL FINDINGS AND SERUM IRON PARAMETERS INCLUDING HEPCIDIN IN PATIENTS WITH IRON DEFICIENCY ANEMIA

EHA Library, Meltem Kurt Yüksel, 324280

THROMBOCYTOPENIA AS AN INITIAL FINDING IN IRON DEFICIENCY ANEMIA

EHA Library, Espen Arnesen Winsnes, 324281

THE ANALYSIS OF THE FIRST HEMATOLOGICAL CONSULTATIONS IN CROATIAN HEMATOLOGY OUTPATIENT CLINICS - A KROHEM STUDY

EHA Library, Marijo Vodanovic, 324282

AGE AND IRON STATUS IN PATIENTS WITH HFE MUTATIONS AT FIRST TIME REFERRAL TO PHLEBOTOMY

EHA Library, Miriam Sandnes, 324283

HYPERFERRITINEMIA IN HETEROZYGOUS H63D AND HYPERTRIGLYCERIDEMIA

EHA Library, Maria Angustias Molina-Arrebola, 324284

U2AF1 MUTATION PROMOTES TUMORIGENICITY THROUGH FACILITATING AUTOPHAGY FLUX MEDIATED BY FOXO3A ACTIVATION IN MYELODYSPLASTIC SYNDROMES

EHA Library, Lingyun Wu, 324291

THE UTILITY AND OUTCOME OF NEXT GENERATION SEQUENCING IN THE DIAGNOSTIC WORK UP OF PATIENTS WITH UNEXPLAINED CYTOPENIA AT A PRIMARY REFERRAL CENTER

EHA Library, Dicte Træden, 324292

MUTATIONAL PROFILE AND IMMUNOPHENOTYPIC CHANGES IN BONE MARROW COMPARTMENTS OF CHRONIC MYELOMONOCYTIC LEUKEMIA PATIENTS

EHA Library, João Gaião Santos, 324293

A PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF LUSPATERCEPT VERSUS EPOETIN ALFA FOR THE TREATMENT OF ANEMIA DUE TO LOWER-RISK MDS IN ESA-NAIVE PATIENTS REQUIRING RBC TRANSFUSIONS (THE COMMANDS TRIAL)

EHA Library, Matteo Della Porta, 324296

SWITCHING TO AN ALTERNATIVE RECOMBINANT ERYTHROPOIETIN AGENT MAY BE EFFECTIVE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME

EHA Library, Bruno Fattizzo, 324302

A CLINICAL STUDY ON MYELODYSPLASTIC SYNDROMES

EHA Library, Adela Perolla, 324303

UNRAVELLING RESISTANCE MECHANISMS TO PROTEASOME INHIBITORS IN MULTIPLE MYELOMA

EHA Library, Maria Carolina AFONSO, 324305

EFFECTS OF DARATUMUMAB(DARA), CYCLOPHOSPHAMIDE (C), THALIDOMIDE (T) AND DEXAMETHASONE (D) COMBINATION ON LYMPHOCYTE POPULATIONS OF TRANSPLANT ELIGIBLE NEWLY DIAGNOSE MULTIPLE MYELOMA PATIENTS

EHA Library, Allan Santos, 324306

CYTOKINE GENE POLYMORPHISMS AND AUTOLOGICAL TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Svetlana Svitina, 324309

THE POTENTIAL DIAGNOSTIC ROLE OF CD138+/BCMA+/CD319+ MICROPARTICLES FROM THE PLASMA CELL IN MULTIPLE MYELOMA CLINICAL MONITORING BY FLOW CYTOMETRY

EHA Library, Nanhao Meng, 324310

COMPARISON OF THE EXPRESSION PROFILE AND PROMOTER GENE METHYLATION OF SELECTED TUMOR-SUPPRESSOR GENES IN MYELOMA CELLS

EHA Library, Katerina Smesny Trtkova, 324314

EFFICACY AND SAFETY OF VENETOCLAX COMBINATIONS IN T(11;14) MULTIPLE MYELOMA: REAL WORLD DATA OF 50 PATIENTS COLLECTED FROM 7 HUNGARIAN CENTERS

EHA Library, Virág Szita, 324315

OUTCOMES OF DARATUMUMAB-CONTAINING REGIMENS IN THE TREATMENT OF RELAPSED MULTIPLE MYELOMA: REAL-WORLD DATA FROM THE CANADIAN MYELOMA RESEARCH GROUP DATABASE

EHA Library, Richard LeBlanc, 324317

IN-CLASS TRANSITION FROM INTRAVENOUS TO ORAL PROTEASOME INHIBITOR AS LONG PROTEASOME INHIBITION IN NEWLY DIAGNOSED AND FIRST RELAPSED MULTIPLE MYELOMA PATIENTS IN CHINA: A REAL-WORLD STUDY

EHA Library, Aijun Liu, 324320